1. The Oncology Care Team

3. The Biosimilar Era Is Here

4. Overview of Biosimilars

5. FDA Definition of Biosimilar Products

6. Stepwise Process for Demonstrating Biosimilarity

7. Extrapolation of Indications

8. Concept of Interchangeability

9. Hematology/Oncology Products With Approved Biosimilar(s)

10. Potential Patient Concerns About Biosimilars

11. Variation Exists With All Biologics

12. Patient Communication Essentials

13. Addressing Patient Concerns About Biosimilars

14. Ongoing Surveillance of Biosimilars

15. Educate Yourself, Educate Your Patient

16. Biosimilar Uptake Roles of Pharmacists

17. Biosimilar Uptake Roles of Nurses

18. Transitions in Care May Present Challenges

19. Shared Decision-Making and Informed Preferences

20. Educational Resources for Patients and HCPs

21. Key Takeaways

22. Abbreviations